Publications by authors named "Louis M Aledort"

Claim this Profile
E
Emicizumab in Hemophilia A. Reply.
Louis M Aledort

N Engl J Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deaths Associated with Emicizumab in Patients with Hemophilia A.
Louis M Aledort

N Engl J Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ongoing imperative for immune tolerance induction in inhibitor management.
Louis M Aledort

Haemophilia· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Louis M Aledort, Bruce M Ewenstein

N Engl J Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Congenital Thrombotic Thrombocytopenia Purpura: A New Paradigm.
Louis M Aledort, Tammuella C Singleton, Paula J Ulsh

J Pediatr Hematol Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia.
James B Bussel, David J Kuter, Louis M Aledort, Craig M Kessler, Adam Cuker

Blood· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.
Brian M Elliott, Louis M Aledort

Expert Rev Hematol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IVIG--a hemolytic culprit.
Sofya Pintova, Aarti S Bhardwaj, Louis M Aledort

N Engl J Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
Jeffrey Bander, Sammy Elmariah, Louis M Aledort, Jeffrey Dlott, Paul Stelzer

Thromb Haemost· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FEIBA: a prohemostatic agent.
Caroline Cromwell, Louis M Aledort

Semin Thromb Hemost· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An algorithmic approach to peripheral artery disease in hemophilia: extrapolation of management principles from noncoagulopathic patients.
Patrick F Fogarty, Jeffrey W Olin, Craig M Kessler, Barbara A Konkle, Louis M Aledort

Blood Coagul Fibrinolysis· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of factor XI deficiency.
Louis M Aledort

Clin Adv Hematol Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-label use of recombinant activated factor VII--safe or not safe?
Louis M Aledort

N Engl J Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening coagulation testing using the APTT: which reagent to choose?
Francine R Dembitzer, Yvelisse Suarez, Louis M Aledort, Ellinor I B Peerschke

Am J Hematol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of anti-D during pregnancy.
Caroline Cromwell, Michael Tarantino, Louis M Aledort

Am J Hematol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Review of Hematology: addressing the needs of a broad research field.
Louis M Aledort

Expert Rev Hematol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent orthostatic global amnesia in a patient with postoperative hyperfibrinogenemia.
Brett A Sealove, Louis M Aledort, Charles B Stacy, Jonathan L Halperin

J Stroke Cerebrovasc Dis· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
David J Kuter, James B Bussel, Roger M Lyons, Vinod Pullarkat, Terry B Gernsheimer, Louis M Aledort

Lancet· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: a case series and review of the literature.
Ivy Altomare, Alan Adler, Louis M Aledort

Thromb J· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990.
James J Goedert, Bingshu E Chen, Liliana Preiss, Louis M Aledort, Philip S Rosenberg

Am J Epidemiol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
James B Bussel, David J Kuter, James N George, Robert McMillan, Louis M Aledort

N Engl J Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echinocytosis--an unusual manifestation of hemangioma.
Ivy Altomare, Garrett Desman, Louis M Aledort

Am J Hematol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
United States' factor XI-deficiency patients need a safer treatment.
Louis M Aledort, Jenny Goudemand,

Am J Hematol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic choices in the current millennium: hemophilia workshop highlights.
Prasad Mathew, Catherine S Manno, Louis M Aledort

Pediatr Blood Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in clotting factor treatment for congenital hemorrhagic disorders.
Michael D Tarantino, Louis M Aledort

Clin Adv Hematol Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis